About AstraZeneca
Headquartered in London, AstraZeneca was formed on April 6, 1999, from the merger of Astra AB of Sweden and Zeneca Group PLC of the United Kingdom. Our products are available in more than 100 countries. More than 66,000 employees worldwide help AstraZeneca make innovative and effective medicines available for a wide range of serious diseases. AstraZeneca research is leading the way in cardiovascular disease, breast and prostate cancer, gastrointestinal disease, asthma/COPD, schizophrenia and bipolar disorder.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
- Industry : Pharma
